More than 170 UCI Health doctors among 2020 Physicians of Excellence in Orange Coast magazine

/ /by

List includes more doctors than any other Orange County hospital, health system

More than 170 UCI Health doctors have been named to the 2020 Physicians of Excellence list published in the January 2020 edition of Orange Coast magazine, more than that of any other health system in Orange County.

The recognition is bestowed by the Orange County Medical Association, a voluntary physician organization that exists to promote the art and science of medicine, the protection of public health and the betterment of the medical profession.

The complete list includes more than 560 Orange County physicians in 75 specialties. The magazine is on newsstands now.

This year, UCI Health received an 11th consecutive top grade for patient safety from The Leapfrog Group and was listed among America’s Best Hospitals for the 19th year in a row by U.S. News & World Report. The report highlights the excellence of UCI Health programs in gynecology, No. 20 (tie), gastroenterology & GI surgery, No. 36 and geriatrics, No. 42 (tie) among similar programs nationally. The medical center is ranked No. 10 in California

UCI Health doctors practice across the region, in addition to the UCI Medical Center in Orange. Primary and specialty care locations include the Gottschalk Medical Plaza in Irvine and offices in Costa Mesa, Tustin, Yorba Linda, Orange, Placentia, Corona and Chino Hills.

In coastal Orange County, UCI Health specialty care in cancer, breast health, digestive diseases, plastic surgery, neurosurgery and dermatology is available at the Pacific Medical Plaza in Costa Mesa and Newport. Urology, executive health, behavioral health and sleep medicine services are available at the UCI Health Newport — Birch Street office, which opened in 2018.

To be eligible for OCMA recognition, physicians were required to:

  • Be certified by a member board of the American Board of Medical Specialties, a member board of the American Board of Osteopathic Medical Specialties, or an equivalency board recognized by the Medical Board of California or Osteopathic Medical Board of California
  • Be in good standing with the Medical Board of California or Osteopathic Medical Board of California
  • Maintain a primary practice in Orange County for the last five years
  • Be in practice within his/her specialty for the last five years

Physicians were required to demonstrate achievements in at least two of the following criteria: physician leadership; teaching/mentoring; medical research/scientific advances; and humanitarian service.

UCI Health comprises the clinical enterprise of the University of California, Irvine. Patients can access UCI Health at primary and specialty care offices across Orange County and at its main campus, UCI Medical Center in Orange, California. The 402-bed acute care hospital provides tertiary and quaternary care, ambulatory and specialty medical clinics, and behavioral health and rehabilitation services. UCI Medical Center features Orange County’s only National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center and regional burn center. UCI Health serves a region of nearly 4 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us on Facebook and Twitter.

UCI Health Beckman Laser Institute & Medical Clinic Physicians of Excellence for 2019:

Dermatology
Kristen M. Kelly, MD

Facial Plastic and Reconstructive Surgery
Brian J. F. Wong, MD

Neurology
Yama Akbari, MD
Mark J. Fisher, MD

Read full UCI Health article.

Yan Li awarded AHA Postdoctoral Fellowship

/ /by

Yan Li, a fourth year UCI biomedical engineering graduate student in Professor Zhongping Chen’s laboratory was awarded a 2020 two-year American Heart Association (AHA) postdoctoral fellowship.  The research funding is helping her develop and test the integrated intravascular ultrasound/polarization-sensitive OCT device for evaluating atherosclerotic plaque.

Li, who earned a degree in electronic science and technology from Tianjin University in China, is developing a comprehensive intravascular imaging device that can identify plaque, the cause of most heart attacks, in blood vessels. Her device combines photon and ultrasound, which can obtain structure and composition of arterial tissue simultaneously, and provide a quantitative way for clinicians to identify vulnerable lesions, tailor intervention therapy and monitor disease progression.

The AHA awards predoctoral fellowships to promising graduate students whose research relates to cardiovascular function, disease and stroke or to related problems, and who intend to pursue careers aimed at improving global cardiovascular health.

Oral Cancer Screening Technology Makes Big Impact on Underserved Community

/ /by

Story courtesy of Ethan Perez, UCI Beall Applied Innovation

Oral health took the main stage at a recent event at Concorde College celebrating the community partnership between the Concorde College of Dental Hygiene and Dr. Petra Wilder-Smith and her team from UC Irvine Beckman Laser Institute & Medical Clinic (BLIMC).

Among the guests were Robynn Zender, community health research representative at the UCI Institute for Clinical and Translational Science (ICTS); Dr. Wilder-Smith, director of dentistry at UCI BLIMC and professor of surgery at the UCI School of Medicine; former Sen. Janet Nguyen of the 34th district, who regularly supports health clinics hosted by Concorde College; and Dr. Arezou Goshtasbi, director of dental hygiene at Concorde College.

Held at the Garden Grove campus, the collaboration was part of a grant funded by the ICTS with which Wilder-Smith and her team developed a nonsurgical approach to identify oral cancer risk and progression in underserved populations. To achieve this, Wilder-Smith and team used advanced imaging technologies and leveraged the students and facilities at Concorde College to provide free oral cancer screenings to patients at the college’s health clinics.

In addition to screening thousands of patients and identifying those with or at high risk of developing oral cancer, Concorde College has – as a result of this collaboration – expanded its oral cancer curriculum to better prepare the next generation of hygienists for recognizing patients with oral cancer or pre-oral cancer.

“The partnership gave our students the opportunity to be more engaged in research and the importance of collaborating with other health care providers,” said Cherie Wink, instructor of dental hygiene at Concorde College and colleague of Wilder-Smith. “It was a great opportunity to be part of something that could potentially save lives.”

Wilder-Smith, who has made a career of using optics and photonics technologies to improve oral health and who has several patents to her name through UCI Beall Applied Innovation, praised the partnership’s role in helping pre-dental students at UCI.

“Working with Concorde has really added to the pre-dental experience for our students,” said Wilder-Smith. “We don’t have a dental school at UCI so the pre-dental students have to find their own way to make connections to clinical dentistry. Concorde works together with both our dental societies and makes sure the students get pre-clinical experience in helping at free clinics. I think it’s a big deal because it gets them set on the path of volunteering, of doing something for the community.”

The visit included a demonstration of the device used at the free screenings, allowing contributors and supporters to see the culmination of everyone’s hard work.

“I see the proposal, I see the reviews, we give them the money, I talk with them on the phone and I hear Petra talk about the work that she’s doing,” said Zender, who facilitated the funding of the collaboration. “But to actually come here and see the actual devices in action … it’s really rewarding.”

Learn more about UCI BLIMC’s vision of moving innovative technologies from “laboratory benchtop to patient bedside.”

Read full article in UCI Beall Applied Innovation Making Waves.

Pictured (from left to right): Kairong Lin, Robynn Zender, Dr. Petra Wilder-Smith, former Sen. Janet Nguyen, Dr. Arezou Goshtasbi, and Ryan Cheung.

Elliot Botvinick Named Entrepreneurial Leader of the Year

/ /by

On May 29, 2019, Elliot Botvinick was named Entrepreneurial Leader of the Year award at the UCI Innovator Awards Ceremony held by UCI Applied Innovation at The Cove.  This award is given to innovators who have shown an enterprising spirit by transforming at least one significant innovation from the university into a market-ready product or service. The many nominees for this award included Chris Barty, Jeffrey Krichmar, Aimee Edinger, Elliot Botvinick, and Tony Givargis. Elliot Botvinick is a professor at the UCI Henry Samueli School of Engineering. He is considered to be a leader for the research and development of advanced medical devices while also knowing how to bring this research to commercialization. His current research is aimed at treating and diagnosing Type-1 diabetes, as well as standard trauma. He and his research team developed a continuous monitor that measures blood lactate, which helps to identify early signs of organ failure. All of the nominees and winners of these awards are considered to be among the best researchers in and around UCI.

Modulated Imaging Enters Growth Phase with New Name

/ /by

Modulated Imaging Raises $7M in Series B Funding

/ /by


Lumitron’s New Platform is Game-changing

/ /by
Read more

Bruce Tromberg to lead the NIBIB

/ /by

Bruce Tromberg, Ph.D., director of the Beckman Laser Institute and Medical Clinic since 2003 and professor of biomedical engineering and surgery at the University of California, Irvine, has been chosen by the National Institutes of Health to head the National Institute of Biomedical Imaging and Bioengineering.

Read full UCI News article.

Renaissance in light

/ /by

“We are in a renaissance in light source technology,” stated Dr. Chris Barty, who joined UCI and the BLIMC as professor of Physics and Astronomy in July. And “Renaissance Man,” is one way to describe Barty.

With Ph.D. and M.S. degrees in applied physics from Stanford University and B.S. degrees, each with honors, in chemistry, physics, and chemical engineering from North Carolina State University, Barty joined UCI after serving as the chief technology officer for the National Ignition Facility (NIF) and Photon Science Directorate. Prior to that he was the founder and director of the mission-based Photon Science and Applications program at Lawrence Livermore National Laboratory (LLNL).

At LLNL, Barty helped manage and guide the technical evolution of the world’s highest-energy and largest laser within the NIF – a laser the size of a football stadium. He also played key roles in the development of ultrahigh intensity laser science, laser inertial fusion energy and laser defense activities at LLNL. For more than a decade, Barty has also pioneered laser-Compton technology, an extremely bright, x-ray and gamma-ray light source that can be created with short-pulse lasers and energetic electron beams. In the gamma-ray spectral region, the peak brightness of a laser-Compton light source pulse can be 15 orders of magnitude beyond any other man-made light, making it possible to access and manipulate the nucleus of an atom with photons, an emerging field known as “nuclear photonics.” These highly mono-energetic gamma-ray sources produce narrow, laser-like beams of incoherent gamma rays that can penetrate through lead and other thick containers and can be tuned to a specific energy so they predominately interact with only one kind of material.

“In the early days of lasers, the controlled manipulation of the outermost electron structure of the atom became possible, leading to a wide variety of new applications and science that now impacts many, many aspects of our daily lives,” stated Barty. “Similarly, laser-Compton gamma-ray sources are now enabling ‘nuclear photonics,’ or the photon-based manipulation of proton motion within the nucleus, and thus are leading to new applications and science including the isotope-specific detection of materials for security and advanced medical imaging, and enable novel forms of discovery-class, nuclear spectroscopy.” Since Barty first coined the term “nuclear photonics” in 2008, the related international community has grown rapidly and now includes more than $500 million of activities and a major biennial conference by the same name.

“[At LLNL] We constructed a proof-of-principle laser-Compton machine and used its photons to detect the presence of lithium concealed behind aluminum and lead,” shared Barty. “The machine created a record peak brilliance. It used an existing linear accelerator and custom laser systems designed specifically for laser-based Compton scattering x-ray and gamma-ray sources.”

Barty’s patented laser-Compton technology is now being transferred to industry, and is the foundation behind a new company, Lumitron Technology, Inc., which he helped launch and which will be headquartered in the University Research Park adjacent to campus. As the lead hire in the Convergence Optical Sciences Initiative (COSI), he will concentrate his efforts on building the world’s highest output, tunable, mono-energetic, compact, x-ray light source based on laser-Compton scattering. “My focus will not only be to establish laser-Compton systems as the ‘gold standard’ for imaging and therapy, but also to target a broad ecosystem of new science and technology across a range of industrial, commercial and healthcare applications.”

“When I look here [at UCI], I see the grand vision. BLIMC completely gets the story where academic and industrial activities are encouraged which doesn’t happen everywhere,” stated Barty.

“We are pushing the frontier of basic science and engineering. Laser-Compton technology will enable the location, study and treatment of disease in ways not previously possible. We have a tremendous opportunity to change healthcare and make a real impact on medicine. The unique x-ray capabilities of compact, laser-Compton sources will also play a pivotal role in materials science, micro-fabrication, and the rapid emergence of additive manufacturing.”